Prof. Dr. Dennis Säring is a faculty member at the University of Applied Sciences Wedel , specifically affiliated with the School of Engineering. His academic and research activities focus on Deep Learning , Medical Image Analysis , and applications of Artificial Intelligence in healthcare and biomedical imaging. He has led seminars on Deep Learning topics and supervised student projects in Autonomous Driving at Audi's AADC 2018 competition. Research Highlights : Cardiovascular imaging, forensic age estimation via MRI, neural network-based bone segmentation, and cerebrovascular aneurysm analysis. Technical Expertise : Cardiac MRI, 3D/4D image processing, parametric mapping, and spatiotemporal data fusion. His recent publications (2018-2023) emphasize 3D MR segmentation for age assessment, CMR strain analysis in athletes, and T1/T2 mapping for myocarditis. Key collaborations include institutions like the University Medical Center Hamburg-Eppendorf and Wedler Hochschulbund, with funding for autonomous vehicle research. While no explicit scientific awards are listed, his work spans clinical cardiology, forensic radiology, and AI-driven medical diagnostics.
Dr. Kristen M George serves as an Assistant Professor of Epidemiology in the Department of Public Health Sciences at the University of California, Davis, School of Medicine. Her academic journey includes a BA in Political Science with minors in Public Health and Anthropology from Washington University in St. Louis, followed by an MPH and PhD in Epidemiology with a minor in Biostatistics from the University of Minnesota (completed in 2015 and 2019 respectively). Dr. George's research program focuses on lifecourse vascular contributions to dementia and cognitive aging, with particular emphasis on race and sex disparities. She investigates how social determinants lead to inequities in cardiovascular risk factors and disease, which subsequently contribute to disparities in cognitive aging and dementia outcomes. Her work bridges epidemiology, neurology, and social determinants of health to address critical gaps in understanding dementia disparities. Analysis of her recent publications reveals a strong focus on African American health, life course epidemiology, and structural determinants of cognitive aging. Her research frequently examines how historical and contemporary social factors impact neurological outcomes in diverse populations, with particular attention to cardiovascular pathways to dementia. Professional recognition includes: Center for the Advancement of Multicultural Perspectives on Science (CAMPOS) Scholar, UC Davis (2021) NIH Travel Award (2020) JB Hawley Student Research Award, University of Minnesota (2016) Dr. George is an active member of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment and the Methods in Longitudinal Dementia Research community, contributing to both national and international efforts to understand and address dementia disparities through rigorous epidemiological approaches.
Carina Mallard is Professor of Experimental Perinatal Brain Injury Research and Pro-Vice-Chancellor at the University of Gothenburg since July 2023, where she oversees research infrastructure and chairs the Research Board. She previously served as Deputy Vice-Chancellor (2021–2023) and Head of Core Facilities (2018–2021). Her academic career began with a Physiology degree from Lund University and a PhD in Pediatrics at the University of Auckland (1995), followed by a professorship appointment in 2006. Her research focuses on perinatal brain injury , particularly in premature infants , investigating neuroinflammatory mechanisms maternal dietary interventions neurovascular unit dynamics microglia activation long-term consequences of maternal obesity . Recent publications highlight her work on neonatal rodent models , transcriptomic profiling , and anti-inflammatory therapies . Key themes include RNA degradation , mitochondrial protection , and immune-neurovascular interactions . She has supervised 20 doctoral students since 2004 and collaborates internationally with institutions like King's College London. Contact details include two institutional emails and physical addresses across Gothenburg's biomedical campuses. Her leadership roles span research strategy, doctoral education, and EU-level scientific initiatives.
Changhuei Yang is the Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering at California Institute of Technology, serving as Executive Officer for Electrical Engineering and Investigator at Heritage Medical Research Institute. He holds a Ph.D. and three master's degrees from MIT, with appointments at Caltech since 2003. Research focuses on: Advanced microscopy techniques including Fourier Ptychography Wavefront shaping for biological tissue imaging Optical phase conjugation for deep-tissue applications Compact medical devices for cerebral monitoring Publications demonstrate leadership in computational imaging, with recent advances in stain-free embryo analysis, portable cerebral blood flow monitors, and high-resolution volumetric imaging techniques using neural representations. Honored as National Academy of Inventors member. Research applications span deep-tissue biochemical imaging, incisionless surgery, and optogenetic activation systems.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Daniel Razansky is a Full Professor at the Department of Information Technology and Electrical Engineering, ETH Zurich, leading the Professorship for Biomedical Imaging. His research spans engineering, physics, biology, and medicine, focusing on developing advanced in vivo imaging tools like optoacoustic tomography and ultrasound neuromodulation. His recent work emphasizes multi-scale functional and molecular imaging , with applications in neuroscience , Alzheimer’s disease , and stroke diagnostics . Collaborations include National Tsing Hua University and the EU Horizon consortium SWEEPICS. Current projects target hybrid imaging systems (e.g., MRI-MSOT) and image-guided neuromodulation. Scientific awards include the IPPA James Smith Prize for his contributions. His lab has secured significant grants, including a $2.5M NIH award and SNSF funding. He mentors PhD students like Quanyu Zhou and Eva Remlova, who have received accolades for their research. The Razansky Lab at ETH Zurich’s Preclinical Imaging Center explores medical microrobotics , dynamic fluid flow imaging , and neuroimaging techniques , aiming to bridge engineering with clinical applications.
Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.
Chris B. Schaffer is a Professor in the Meinig School of Biomedical Engineering at Cornell University, specializing in developing advanced optical techniques to study neurovascular dynamics in neurological diseases. His lab focuses on Alzheimer’s disease mechanisms, leveraging multiphoton microscopy and in vivo imaging to explore capillary stalling, cerebral blood flow deficits, and their cognitive impacts. He holds a Ph.D. in Physics from Harvard University and postdoctoral training in neuroscience at UC San Diego. Research interests include biomedical imaging instrumentation, neurodegenerative disease modeling, and science education innovation. Awards include AAAS Fellowship (2021), AIMBE Fellowship (2019), and multiple teaching accolades. His work bridges engineering and medicine, with contributions to spinal cord injury studies, epilepsy, and vascular contributions to dementia (VCID). Notable discoveries include identifying neutrophil-induced capillary stalls as a key Alzheimer’s disease mechanism and demonstrating cerebral blood flow improvements can restore memory in mouse models. His lab also develops educational tools emphasizing science as a discovery process, used in K-12 and university settings.
Matthew B Potts, MD is an Associate Professor in the Department of Neurological Surgery at Northwestern University's Feinberg School of Medicine, with secondary appointments in Neurology (Ken and Ruth Davee Department) and Radiology. His clinical expertise spans cerebrovascular surgery, neurointerventional/endovascular procedures, and management of brain aneurysms, vascular malformations, stroke, and spinal vascular disease across multiple Northwestern Medicine hospitals including Shirley Ryan AbilityLab. Dr. Potts completed his BS at MIT (2000) and MD at UCSF (2007), followed by surgical internship (2008), neurological surgery residency (2013), and cerebrovascular fellowship at NYU (2015). BS: Massachusetts Institute of Technology (2000) MD: University of California, San Francisco (2007) Internship: University of California-San Francisco Medical Center, Surgery (2008) Residency: University of California-San Francisco Medical Center, Neurological Surgery (2013) Fellowship: New York University Medical Center, Endovascular/Cerebrovascular Surgery (2015) His research program centers on chronic subdural hematoma pathophysiology, emergency stroke thrombectomy process optimization, and aneurysm treatment outcomes. He employs clinical-translational approaches to improve cerebrovascular disease management through advanced surgical techniques and rigorous outcomes assessment. Recent 2025 publications reveal strong focus on hydrocephalus diagnostics, hematoma expansion biomarkers, vertebrobasilar anatomy, and dolichoectatic aneurysm natural history. These works demonstrate multidisciplinary collaboration across neurosurgery, neurology, and radiology to advance diagnostic precision and treatment efficacy in complex cerebrovascular disorders. Dr. Potts has received exceptional recognition for medical education, including three consecutive Outstanding Teacher Awards (2019-2021) and the John X. Thomas, Jr. Best Teachers Award (2020). His research contributions are honored by the NIH Rush L. Kirschstein Award (2012) and Howard Hughes Fellowship (2005). Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2021) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) John X. Thomas, Jr. Best Teachers of Feinberg Award, Northwestern University Feinberg School of Medicine (2020) Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2019) Ivan Ciric Resident Teaching Award, Northwestern University Department of Neurological Surgery (2017) Best Scientific Presentation, UCSF Department of Neurological Surgery (2013) NIH Rush L. Kirschstein National Research Service Award, National Institutes of Health (2012) UCSF School of Medicine Alumni Scholarship Award, University of California, San Francisco (2006) Howard Hughes Medical Institute Medical Student Research Fellow, Howard Hughes Medical Institute (2005) UCSF Quarterly Research Fellowship, University of California, San Francisco (2005) MIT-Germany Program Research Fellowship, Massachusetts Institute of Technology (2001) As an educator, Dr. Potts mentors medical students and residents through Feinberg's neurological surgery program, evidenced by his resident teaching award. His research is supported by institutional resources and prior NIH funding, with current industry relationships including ownership in Rhaeos, Inc. He serves as Assistant Editor for Neurosurgery and Associate Editor for Operative Neurosurgery. He operates within Northwestern's integrated neurovascular team across multiple hospital sites, collaborating with neurologists, neuroradiologists, and rehabilitation specialists to deliver comprehensive care for complex cerebrovascular conditions, with ongoing work focused on improving health equity in stroke treatment and minimally invasive surgical innovation.
Frank E. Garcea, Ph.D., is a Research Assistant Professor in the Department of Neurosurgery and Neuroscience at the University of Rochester School of Medicine and Dentistry. His research focuses on the cognitive and neural mechanisms underlying tool use, apraxia, and stroke recovery. He employs neuropsychological testing, fMRI, and lesion-symptom mapping to study brain injury effects on functional connectivity and action knowledge. Education: Bachelor of Science in Psychology, St. John Fisher College (2006–2010) PhD in Brain and Cognitive Sciences, University of Rochester (2012–2017) Research Interests: Dr. Garcea investigates how brain regions like the parietal cortex and dorsal/ventral streams mediate object manipulation and tool use. His work explores stroke-related disconnection syndromes, motor speech coordination networks, and translational brain mapping to preserve neural function during surgery. He collaborates on projects involving epilepsy patients undergoing electrocorticography to study action-related neural pathways. Labs & Affiliations: Principal Investigator of the Garcea Lab at URMC, focusing on tool use deficits in brain tumor/stroke survivors. Affiliated with the Del Monte Institute for Neuroscience and the Neurobiology & Anatomy Program. His lab integrates neuroimaging, lesion analysis, and clinical care to advance personalized brain mapping strategies.
George E. Vates, MD, PhD, is a Professor in the Department of Neurosurgery and the Department of Medicine (Endocrine/Metabolism) at the University of Rochester Medical Center. He serves as neurosurgeon co-director of the University of Rochester Multidisciplinary Neuroendocrinology Clinic and is a key member of the University of Rochester Medical Faculty Group (URMFG), which comprises over 900 providers across 19 departments. Dr. Vates specializes in pituitary tumor surgery, cerebrovascular disorders, and skull base procedures, having performed over 120 transsphenoidal pituitary surgeries. Dr. Vates completed his academic training with exceptional distinction: Duke University: Bachelor's degree, summa cum laude (1988, Phi Beta Kappa) Rockefeller University: PhD in Neuroscience Weill Medical College of Cornell University: MD (1997, Alpha Omega Alpha) University of California, San Francisco: Neurosurgery Residency (1998-2003) Brigham and Women's Hospital, Harvard Medical School: Cerebrovascular/Skull Base Fellowship (2003-2004) His research focuses on pituitary tumor biology, neuroendocrinology, and surgical innovation. He established the Multidisciplinary Neuroendocrinology Clinic as a regional referral center for complex pituitary cases, integrating neurosurgical and endocrinological expertise. Current work emphasizes neuroprotective mechanisms in pituitary adenomas, surgical simulation technology, and optimizing outcomes for elderly glioma patients. Analysis of his 15 most recent publications reveals evolving research trajectories: contemporary studies (2019-2022) concentrate on pituitary tumor management, surgical simulation, and neurosurgical education, while earlier work (2002-2009) explored cerebrovascular anomalies, neural pathway mapping, and vascular malformations. Persistent themes include surgical technique refinement, tumor biology, and clinician training. Dr. Vates' scientific contributions have been recognized through: Phi Beta Kappa (1988) and Alpha Omega Alpha (1991) academic honors Neurosurgery Research and Education Foundation Fellowship (2006) Anspach Award for Cerebral Ischemia Research (2007) AANS Leadership Scholarship and Cone Pevehouse Award (2009) Ongoing service as St. Michael's Hospital Animal Care Committee reviewer As an educator, he mentors neurosurgery residents through clinical supervision and curriculum development, notably publishing on palliative care communication training. His research initiatives, including the 3D-printed cervical laminectomy simulator, demonstrate commitment to advancing surgical education. Current grants focus on neuroprotective strategies in pituitary tumors and resident training methodologies. Dr. Vates co-directs the Multidisciplinary Neuroendocrinology Clinic with endocrinologist Dr. Calvi, fostering collaboration between neurosurgery, endocrinology, and oncology. His clinical team manages complex pituitary cases across Rochester and Hornell campuses, while his research group develops surgical innovations and investigates tumor microenvironment interactions to improve patient outcomes.
Teresa Cheung is an Adjunct Professor in the Department of Engineering Science at Simon Fraser University’s Faculty of Applied Sciences. Her research focuses on neuroimaging techniques, particularly magnetoencephalography (MEG), and their applications to understanding brain networks in health and disease. She holds a Ph.D. in Physics from SFU (2012) and completed a postdoctoral fellowship at the University of Cambridge (2012–2013). Research interests include: MEG instrumentation and optically pumped magnetometers (OPM) Cortical-cerebellar networks and cerebellar activity localization Neuroimaging of neurological disorders like major depressive disorder and epilepsy Functional and structural connectome analysis across the human lifespan Multimodal integration of MEG, MRI, fMRI, and DTI data Recent work emphasizes the relationship between cardiovascular health, brain aging, and cognitive resilience. Her studies span clinical applications (e.g., depression biomarkers) and technical advancements in neuroimaging systems. Collaborations include multi-site studies on depression and aging cohorts like the Cam-CAN project. Publications highlight innovative methods in MEG system design, neural network dysfunction analysis, and lifespan brain dynamics. Her work bridges engineering, neuroscience, and clinical research to advance non-invasive brain imaging and neurophysiological understanding.
Associate Professor Richard Burns is a Senior Fellow at the Australian National University's National Centre for Epidemiology and Population Health, working within the Department of Health Economics, Wellbeing and Society. With a distinguished academic career spanning epidemiology and population health, he contributes significantly to global health research initiatives including the Global Burden of Disease Study. BMus (ANU) BA (CSU) PGDE (UC) MSc (Manchester) MBiostats (USyd) PhD (USQ) Professor Burns' research focuses primarily on mental health, wellbeing, and the global disease burden, with particular expertise in life expectancy, psychological wellbeing, and dementia. His work bridges epidemiological methods with practical applications for population health improvement. His research fingerprint shows strong concentration in mental health (100%), wellbeing (49%), global disease burden (47%), and life expectancy (25%). His recent publication record demonstrates remarkable productivity, with 112 research outputs including 18 publications in 2024 alone. These works span high-impact journals including The Lancet, The Lancet Neurology, and Genes, focusing on global health metrics, mental health services, cognitive function, and healthy aging across diverse populations. His research shows a clear trend toward interdisciplinary approaches combining epidemiology, neuroscience, and public health policy. Professor Burns has successfully secured multiple research projects, including the Internal Validation of Defence Wellbeing Measure (2023-2025), Mental Health Analysis and Modelling, and the Request for Quotation application: Defence Wellbeing Research Framework. He collaborates extensively with researchers across Australia and internationally. As a registered supervisor, Professor Burns mentors students in epidemiology and population health research. His laboratory work focuses on the PATH through Life Project and other longitudinal studies examining mental health trajectories across the lifespan. His team employs advanced statistical modeling and neuroimaging techniques to understand the complex interplay between biological, psychological, and social determinants of health.
Thomas Longden is an Associate Professor in the Department of Physiology at the University of Maryland School of Medicine. He leads a research group focused on neurovascular interactions in health and disease, with particular emphasis on understanding how blood flows through the brain under normal conditions and how this process is disrupted in diseases like Alzheimer's. Dr. Longden received his B.Sc (Hons) and Ph.D. in Pharmacology from the University of Manchester in the UK (2006 and 2010), followed by postdoctoral training at the University of Vermont under Professor Mark Nelson (2011-2015). He was promoted to Assistant Professor at Vermont in 2015 before joining the University of Maryland in February 2019. His research focuses on the control of blood flow in the brain, particularly the mechanisms of neurovascular coupling where neuronal activity triggers changes in blood flow. His lab has made significant discoveries including identifying the brain's capillary network as a 'sensory web' that translates neural activity into vasodilatory electrical signals, and demonstrating how pericytes function as metabolic sentinels that control blood flow through KATP channel-dependent mechanisms. Analysis of Dr. Longden's recent publications reveals a strong focus on pericyte function in neurovascular coupling, electrical signaling in the capillary network, and how these mechanisms are disrupted in Alzheimer's disease and other dementias. His work increasingly incorporates advanced imaging techniques, computational approaches, and innovative tools to study vascular plasticity. 2023: Fellow of the American Physiological Society Cardiovascular Section 2020: NIH Director's New Innovator Award 2017: American Heart Association Scientist Development Grant Multiple travel awards and postdoctoral fellowships Dr. Longden currently mentors several graduate students and postdoctoral fellows in the Longden Lab, which is supported by multiple NIH grants including an NINDS New Innovator Award and an NIA R01 grant. His lab develops and employs advanced techniques including multiphoton microscopy, electrophysiology, optogenetics, and molecular biology to study vascular cells in the brain. The lab is particularly focused on understanding vascular signaling plasticity and how pericytes control brain blood flow in health and Alzheimer's disease.
Robert Fulbright, MD, is Professor of Radiology and Biomedical Imaging at Yale School of Medicine with a secondary appointment in Neurology. He serves as Medical Director of the Magnetic Resonance Research Center and specializes in neuroradiology, focusing on diagnostic examinations of the brain, head and neck, spine, and peripheral nervous system using CT, MRI, and MR spectroscopy. Dr. Fulbright completed his medical degree at Baylor College of Medicine (1984), followed by residency training at Baylor College of Medicine and Columbia University, and a fellowship at Yale University School of Medicine. He is board certified in both Diagnostic Radiology (1991) and Internal Medicine (1988). His research centers on advanced magnetic resonance techniques to better understand brain function and disease mechanisms, with particular emphasis on Deuterium Metabolic Imaging (DMI) for mapping brain tumor metabolism. His work bridges radiology, neurology, and oncology to improve diagnostic capabilities and patient outcomes. Analysis of his recent publications (2023-2025) reveals three major research thrusts: metabolic imaging of brain tumors using DMI, genomic correlations with imaging findings in meningiomas, and technical innovations in MRI acquisition and processing. His work demonstrates increasing integration of AI techniques with traditional imaging modalities. As Medical Director of the Magnetic Resonance Research Center, Dr. Fulbright oversees a multidisciplinary team working at the forefront of neuroimaging technology. His clinical work focuses on neuroradiology with particular expertise in brain tumor imaging and neurological disorders.
